Lohinai Z - Search Results

1

Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy.

Dora D, Bokhari SMZ, Aloss K, Takacs P, Desnoix JZ, Szklenárik G, Hurley PD, Lohinai Z. Dora D, et al. Among authors: lohinai z. Int J Mol Sci. 2023 Feb 1;24(3):2769. doi: 10.3390/ijms24032769. Int J Mol Sci. 2023. PMID: 36769093 Free PMC article. Review.

2

Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution.

Dora D, Rivard C, Yu H, Bunn P, Suda K, Ren S, Lueke Pickard S, Laszlo V, Harko T, Megyesfalvi Z, Moldvay J, Hirsch FR, Dome B, Lohinai Z. Dora D, et al. Among authors: lohinai z. Mol Oncol. 2020 Sep;14(9):1947-1965. doi: 10.1002/1878-0261.12741. Epub 2020 Jul 18. Mol Oncol. 2020. PMID: 32506804 Free PMC article.

3

Characterization of Tumor-Associated Macrophages and the Immune Microenvironment in Limited-Stage Neuroendocrine-High and -Low Small Cell Lung Cancer.

Dora D, Rivard C, Yu H, Pickard SL, Laszlo V, Harko T, Megyesfalvi Z, Dinya E, Gerdan C, Szegvari G, Hirsch FR, Dome B, Lohinai Z. Dora D, et al. Among authors: lohinai z. Biology (Basel). 2021 Jun 4;10(6):502. doi: 10.3390/biology10060502. Biology (Basel). 2021. PMID: 34200100 Free PMC article.

4

Loss of STING expression is prognostic in non-small cell lung cancer.

Lohinai Z, Dora D, Caldwell C, Rivard CJ, Suda K, Yu H, Rivalland G, Ellison K, Rozeboom L, Dziadziuszko R, Mitchell P, John T, Millan IS, Ren S, Hirsch FR. Lohinai Z, et al. J Surg Oncol. 2022 May;125(6):1042-1052. doi: 10.1002/jso.26804. Epub 2022 Jan 31. J Surg Oncol. 2022. PMID: 35099823 Free PMC article.

5

Protein Expression of immune checkpoints STING and MHCII in small cell lung cancer.

Dora D, Rivard C, Yu H, Pickard SL, Laszlo V, Harko T, Megyesfalvi Z, Gerdan C, Dinya E, Hoetzenecker K, Hirsch FR, Lohinai Z, Dome B. Dora D, et al. Among authors: lohinai z. Cancer Immunol Immunother. 2023 Mar;72(3):561-578. doi: 10.1007/s00262-022-03270-w. Epub 2022 Aug 17. Cancer Immunol Immunother. 2023. PMID: 35978199 Free PMC article.

6

EZCancerTarget: an open-access drug repurposing and data-collection tool to enhance target validation and optimize international research efforts against highly progressive cancers.

Dora D, Dora T, Szegvari G, Gerdán C, Lohinai Z. Dora D, et al. Among authors: lohinai z. BioData Min. 2022 Oct 1;15(1):25. doi: 10.1186/s13040-022-00307-9. BioData Min. 2022. PMID: 36183137 Free PMC article.

7

BRAF RNA is prognostic and widely expressed in lung adenocarcinoma.

Dora D, Vörös I, Varga ZV, Takacs P, Teglasi V, Moldvay J, Lohinai Z. Dora D, et al. Among authors: lohinai z. Transl Lung Cancer Res. 2023 Jan 31;12(1):27-41. doi: 10.21037/tlcr-22-449. Epub 2023 Jan 13. Transl Lung Cancer Res. 2023. PMID: 36762067 Free PMC article.

8

Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers.

Blaj S, Dora D, Lohinai Z, Herold Z, Szasz AM, Herzberg J, Kodacsi R, Baransi S, Schlitt HJ, Hornung M, Werner JM, Slowik P, Acs M, Piso P. Blaj S, et al. Among authors: lohinai z. Cancers (Basel). 2023 Feb 19;15(4):1326. doi: 10.3390/cancers15041326. Cancers (Basel). 2023. PMID: 36831667 Free PMC article.

9

Effective Reversal of Macrophage Polarization by Inhibitory Combinations Predicted by a Boolean Protein-Protein Interaction Model.

Szegvari G, Dora D, Lohinai Z. Szegvari G, et al. Among authors: lohinai z. Biology (Basel). 2023 Feb 27;12(3):376. doi: 10.3390/biology12030376. Biology (Basel). 2023. PMID: 36979068 Free PMC article.

10

Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status.

Dora D, Ligeti B, Kovacs T, Revisnyei P, Galffy G, Dulka E, Krizsán D, Kalcsevszki R, Megyesfalvi Z, Dome B, Weiss GJ, Lohinai Z. Dora D, et al. Among authors: lohinai z. Oncoimmunology. 2023 May 12;12(1):2204746. doi: 10.1080/2162402X.2023.2204746. eCollection 2023. Oncoimmunology. 2023. PMID: 37197440 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page